According to new data, the use of ibuprofen or acetaminophen did not affect the length of a hospital stay for children with asthma.
In three clinical trials, Genentech's new idiopathic pulmonary fibrosis drug Esbriet (pirfenidone) significantly reduced loss of lung function in nearly 50% of participants.
Regeneron Pharmaceuticals and Sanofi revealed positive results from a study of dupilumab in adult patients with asthma.
Percepta Bronchial Genomic Classifier, a new diagnostic test from Veracyte Inc, can assess a person's risk for lung cancer.
Results from the 6-month STELVIO trial validated the safety and efficacy of the Pulmonx Zephyr Endobronchial Valve (EBV) in severe emphysema patients.
The school-based program “Building Bridges for Asthma Care” significantly decreased school absenteeism among children with asthma in inner-city schools enrolled in the program.
Regular aspirin use was associated with a significantly slower progression of percent emphysema over 10 years, when compared to those who did not use aspirin.
Treatment of COPD with inhaled corticosteroids may decrease the risk of dying from pneumonia despite being linked with an increase in pneumonia occurrence.
Certain flavorings used in electronic cigarette liquid may alter important cellular functions in lung tissue, including cell viability, cell proliferation, and calcium signaling.
Critically ill patients who have been mechanically ventilated for more than 7 days are at greatly increased risk for functional impairment and mortality at one year following discharge from the ICU.
The FDA has issued the first warning letters to e-cigarette companies for illegal claims on their websites, according to an article published in JAMA.
New research conducted by German and Swiss researchers reports that air pollution directly affects cognition and is not mediated by lung function.
Although e-cigarettes are widely promoted and used as a smoking cessation tool, researchers found no data supporting their long-term efficacy and safety.
Adding genetic information to a former or current smoker’s clinical risk profile results in a reclassification of their risk for lung cancer in about 1-in-4 patients.
The components of e-cigarettes, including their delivery systems, combustion apparatuses, and composition of nicotine, may affect the levels of potentially hazardous substances in their vapor.
In a study of 2,489 adults with COPD, gastroesophageal reflux disease (GERD), certain scores on the St. George’s Respiratory Questionnaire (SGRQ), and being female were specific risk factors associated with exacerbations of COPD in participants using long-acting controller medication.
A new study reveals that with just one exposure to e-cigarette vapor, participants in a study showed a diminishment of cough reflex sensitivity.
A study to be presented at the American Thoracic Society (ATS) 2015 International Conference shows that a number of children with asthma may have a sensitivity to peanuts but do no know it.
A report from The New York Times discusses the impact of the avian flu viruses that have affected more than 33 million turkeys, chickens, and ducks in more than a dozen states since December.
A new report reveals that young people are just as likely to try e-cigarettes as smoking, with 20% of youth ages 15 to 19 experimenting with vaping.